Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
biology, and translational disease research, and offers strong opportunities for methodological development, interdisciplinary collaboration, and high-impact publications. Your profile We are looking
-
Chart tumour evolution using cutting-edge long-read and single-cell multiomics Who we are The Integrative Cancer Genomics lab (Jonas Demeulemeester) is embedded within the VIB – KU Leuven Center
-
, data acquisition, Ethernet based field buses, machine vision, AI, C / C++, software development, advanced Imaging, spin off. The Mechanical Engineering department of the VUB is looking for a PostDoc
-
The Faculty of Sciences and Bioengineering Sciences, Department Biology, Research Group Ecology, Evolution and Genetics is looking for a postdoctoral researcher with a grant. More concretely your
-
Leuven, Belgium and is part of the VIB-KU Leuven Center for Neuroscience . The Verstreken lab is developing advanced multielectrode array systems to mimic human brain circuits relevant to neurodegenerative
-
investigates the conditions under which perceiving climate change as a threat translates into public support for climate policy. Drawing on the concept of collective victimhood, the project develops a novel
-
administrations in improving the quality of their policy development. The project, entitled “Data Management and Impact Evaluations to Inform Policymaking on the Labour Market integration of Precarious Groups”, is
-
synthetic biology context (check our website at https://csb-bioport.mystrikingly.com/ and www.csb.ugent.be ). You will conduct research on aquaglyceroporin engineering and on the FWO-WEAVE project “Study and
-
. developing the full business plan, including the financial plan and the go-to-market strategy. evaluating and expanding the technological know-how and intellectual property, including the transfer/licensing
-
antibody specificity profiling. KEY RESPONSIBILITIES You’ll join a small team advancing a new screening platform focused on therapeutic antibody specificity. The aim is to deploy this newly developed assay